Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,110,729
+$934,297 QoQ
Shares Held
60,049
-7.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#737
of 4,153 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arvest Bank Trust Division holds $45,815,739 across 8 Drug Manufacturers - General names. ABBV ranks #1 (33.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
60,049 | $15,110,729 | |
| 2 | JNJ |
Johnson & Johnson
|
57,057 | $14,490,765 | |
| 3 | LLY |
ELI LILLY & Co
|
9,403 | $11,278,240 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,386 | $1,848,601 | |
| 5 | PFE |
Pfizer Inc
|
48,596 | $1,170,191 | |
| 6 | NVS |
Novartis AG
|
5,844 | $915,871 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,969 | $747,273 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,011 | $254,069 |
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,110,729 | 60,049 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,176,432 | 65,182 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,153,685 | 66,321 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $15,662,522 | 67,645 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $17,628,516 | 94,971 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $19,965,998 | 95,294 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,885,313 | 89,394 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $18,014,914 | 91,224 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $9,958,018 | 92,315 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,928,877 | 88,147 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $9,305,079 | 85,983 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $8,613,358 | 80,386 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $6,407,120 | 73,149 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $5,927,126 | 60,370 | Shares | Sole | 2020-08-21 | |
| 2020-03-31 | $7,514,237 | 98,625 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||